| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 188.214 | 83 |
| GSM780708 | Untreated after 4 days (C2_1) | 161.717 | 81 |
| GSM780709 | Untreated after 4 days (C3_1) | 161.812 | 81 |
| GSM780719 | Untreated after 4 days (C1_2) | 174.137 | 82 |
| GSM780720 | Untreated after 4 days (C2_2) | 179.75 | 82 |
| GSM780721 | Untreated after 4 days (C3_2) | 198.294 | 83 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 175.796 | 82 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 184.083 | 83 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 192.551 | 83 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 175.54 | 82 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 176.813 | 82 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 198.015 | 83 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 160.672 | 81 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 167.714 | 82 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 154.614 | 81 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 161.691 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 157.351 | 81 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 156.565 | 81 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 244.961 | 86 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 183.247 | 83 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 180.046 | 82 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 211.682 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 191.375 | 83 |